Peptide Antiviral Strategies as an Alternative to Treat Lower Respiratory Viral Infections

Lower respiratory infection caused by human pathogens such as influenza and respiratory syncytial virus (RSV) is a significant healthcare burden that must be addressed. The preferred options to achieve this goal are usually to develop vaccines for prophylaxis and to develop antiviral small molecules...

Descripción completa

Detalles Bibliográficos
Autor principal: Nyanguile, Origène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598224/
https://www.ncbi.nlm.nih.gov/pubmed/31293570
http://dx.doi.org/10.3389/fimmu.2019.01366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598224/
https://www.ncbi.nlm.nih.gov/pubmed/31293570
http://dx.doi.org/10.3389/fimmu.2019.01366

Ejemplares similares